A team of dermatology researchers from L’Oréal’s La Roche-Posay brand have identified an unexpected relationship between the skin microbiome and wound healing, suggesting this presents opportunities for new therapeutic therapies.
A century-old method using live virus bacteriophages has the potential to make its revival in skin care via formulations designed to target blemish-prone skin, says US supplier Biocogent.
Innovation in cosmetic ingredients targeting the skin microbiome is surging, but the ultimate dream is to be able to incorporate beneficial live bacteria into formulations, says a principal scientist at L’Oréal Research & Innovation.